
Materials · Commodity Chemicals
$31.65
-2.63%
Vol: 10.3M
Thursday, June 18, 2026
No material news in the last 48 hours.
No material news in the last 48 hours.
No material news in the last 48 hours.
No material news in the last 48 hours.
No material news in the last 48 hours.
Argus Research upgraded Dow to Buy in May 2026, highlighting positive earnings trajectory momentum. The company's Q1 2026 was weak: net sales fell 6% to $9.8B, operating EPS came in at a loss of $0.14, and volume slipped 2% with local price down 7%. The Board declared a $0.35 quarterly dividend payable June 12 to holders of record May 29. Short interest in Dow rose 13% to over 25M shares as of early May. Stock traded near $39.43 on May 12. Risk: continued chemicals price/volume weakness coupled with rising short interest signals investors remain skeptical that the cycle has bottomed, despite the analyst upgrade.
Dow Inc was upgraded to Buy by Argus Research in early May 2026, with the firm citing global scale and diversified end-market exposure as supporting earnings trajectory improvement. The Board declared a $0.35 quarterly dividend payable June 12, 2026 — the company's 459th consecutive dividend since 1912. Q1 2026 results showed continued weakness with net sales of $9.8B (-6% YoY), GAAP net loss of $445M, operating EBIT of just $154M, and an operating EPS loss of $0.14. Short interest rose more than 13% to over 25 million shares as of early May, reflecting persistent bearish sentiment. The stock traded at $39.43 on May 12 amid broader chemicals sector pressure. Macro headwinds from rising Treasury yields (30-year topped 5.19% on May 19) have weighed on cyclical names including Dow.
Argus Research upgraded Dow Inc. to Buy in May 2026, citing positive momentum in the chemical giant's earnings trajectory and its global scale and diversified end-market exposure. Dow's board declared a quarterly dividend of $0.35 per share payable June 12, 2026 to shareholders of record on May 29, 2026 - the 459th consecutive dividend since 1912. Q1 2026 results showed net sales of $9.8 billion (down 6% YoY), a GAAP net loss of $445 million, and an operating EPS loss of $0.14, reflecting persistent margin pressure. Short interest rose more than 13% to over 25 million shares in early May. The stock traded around $39.43 as of May 12. Risk: weak global manufacturing demand and limited pricing power continue to weigh on profitability despite the dividend yield support.
On May 13, 2026, Argus Research upgraded Dow Inc to Buy from Hold, citing improved earnings momentum and Dow's diversified global end-market exposure. The upgrade follows Q1 2026 results showing net sales of $9.8B (down 6% YoY), a GAAP net loss of $445M, operating EBIT of $154M and an operating EPS loss of $0.14, though cash from continuing operations was $1.1B (up $1.0B YoY) driven by a NOVA payment and working-capital improvements. The board declared a quarterly dividend of $0.35 per share payable June 12, 2026 to holders of record May 29, 2026. At the April 9 annual meeting all director nominees were re-elected and stockholders approved the say-on-pay vote and Deloitte as auditor. Shares were $39.43 as of May 12 with a 68.7% YTD gain noted, outperforming basic materials peers despite weak fundamentals.
Argus Research upgraded Dow Inc to Buy, citing positive earnings momentum, global scale and diversified end-market exposure. The board declared a $0.35 quarterly dividend payable June 12, 2026 to holders of record May 29 — the company's 459th consecutive payout since 1912. Shares closed at $39.43 on May 12, with Dow up 68.7% YTD in the Basic Materials sector and analyst earnings estimates for the year having surged. Affiliate Valtris Specialty Chemicals named Clint Shephard CHRO effective May 4, 2026, based in Midland, Michigan. Dow has navigated mixed macro signals as April CPI rose 3.8% and energy-driven inflation pressures weighed on cyclicals broadly, but the company's execution on cost structure and resin pricing has driven recovery momentum.
Dow Inc reported Q1 2026 net sales of $9.8B (down 6% YoY), a GAAP net loss of $445M, and operating EPS loss of $0.14, with volume down 2% and price down 7%. The company is executing Transform to Outperform, targeting at least $2B near-term operating EBITDA uplift with $1.1-1.5B in one-time costs (including $600-800M severance for ~4,500 roles). Phased savings target $500M in 2026, $1.2B incremental in 2027, $300M incremental in 2028. The board declared a $0.35 quarterly dividend payable June 12, marking the 459th consecutive dividend since 1912. Stock at $39.43 on May 12.
Dow Inc. CEO Jim Fitterling commented in early-mid May that clearing the Strait of Hormuz disruption will take longer than investors expect, with Dow and LyondellBasell positioned to benefit from widening oil and natural-gas spreads as Iran-related turmoil lifts crude prices toward $100-103/bbl. The company is targeting data center liquid cooling and wearable health silicone elastomer markets for growth. The board declared its 459th consecutive quarterly dividend of $0.35/share payable June 12, yielding ~3.7%. Risk: continued global polyethylene/chemicals oversupply pressures pricing and weak European demand.
Dow Inc shares rose 5.1% on May 11, 2026 to $38.76, supported by broader market strength as the Dow Jones Industrial Average gained 95 points to 49,704. Q1 2026 net sales were $9.8 billion, down 6% YoY, reflecting flat Performance Materials Coatings sales and declines across other segments. Following the 2026 Annual Stockholder Meeting, the Board declared a quarterly dividend of 35 cents per share, payable June 12 to shareholders of record May 29, marking the 459th consecutive dividend paid since 1912. Dow is positioned as a key player in the growing data center liquid cooling market. Market sentiment has been impacted by geopolitical tensions including Iran-related oil price moves.
Dow Inc held its 2026 Annual Stockholder Meeting where the Board declared a quarterly dividend of $0.35 per share, payable June 12, 2026 to shareholders of record on May 29, marking the 459th consecutive dividend since 1912. Q1 2026 net sales were $9.8 billion, down 6% year-over-year due to flat sales in Performance Materials Coatings and declines in other operating segments. Broader market pressure from Middle East conflict and oil prices continues to weigh on materials names. The dividend continuity signals balance sheet stability despite cyclical chemicals headwinds. Investors are watching margin compression risks tied to feedstock costs.
| Company | Price | Day | 1M | Fwd P/E | Beta | Mkt Cap |
|---|---|---|---|---|---|---|
| DOWDOW | $31.65 | -2.63% | -12.5% | 14.6x | 0.41 | $22.9B |
| LINLINDE | $512.15 | -0.72% | +1.1% | 26.0x | 0.73 | $236.8B |
| NEMNEWMONT | $104.04 | -1.54% | -3.4% | 9.1x | 0.46 | $110.8B |
| FCXFREEPORT | $68.84 | -0.32% | +12.8% | 17.6x | 1.36 | $98.7B |
| SHWSHERWIN | $321.36 | +2.41% | +4.3% | 24.2x | 1.13 | $79.1B |
| ECLECOLAB | $269.94 | +0.33% | +8.2% | 28.0x | 0.91 | $75.7B |
Price between 50d and 200d. Testing 50d support.